Neela Therapeutics, Inc.
Amendment
CIK: 0002090797·Other Health Care·DELAWARE·Filed: May 26, 2026
Total Offering
$21,510,000
Amount Sold
$13,821,643
Investors
21
First Sale
Nov 14, 2025
Offering Details
- Type
- Debt, Option to Acquire
- Exemptions
- Rule 506(b)
- Entity Type
- Corporation
- Year Incorporated
- 2025
- Non-Accredited Investors
- No
Related Persons
| Name | Role |
|---|---|
| PJ Anand | |
| Norbert Riedel | |
| Richard Upton | |
| David Donabedian | |
| Edgar D. Jannotta Jr. | |
| Stephen Oesterle |
Company
SEC Filing
0002090797-26-000001
View on SEC EDGARWant deeper insights?
Sign up for free to search all filings, track companies, and set up alerts.
Sign Up Free